In the study a new aqueous formulation with the new mosquitocidal isolate of Bacillus cereus VCRC 641 was developed, and the residual activity was assessed from simulated field trials conducted in the natural environment. From laboratory bioassays, it was observed that the efficacy of aqueous formulation of Bacillus cereus was on par with lyophilized cell mass, as such. The LC50 values of formulated B. cereus against Culex quinquefasciatus, Anopheles stephensi and Aedes aegypti were 0.002, 0.009 and 0.008 mg L-1 respectively. Correspondingly, the LC50 values of lyophilized cell mass of B. cereus against these three mosquito species were 0.0019, 0.005 and 0.004 mg L-1 respectively. Finally, simulated field trial was carried out using formulated B. cereus and the residual efficacy against all three mosquito larval species revealed 100 per cent larval mortality up to seven days and 69 to 78 per cent mortality were up to 15 days. Thereafter, the mortality was declining gradually up to 21 days. It is concluded that the formulation of B. cereus may be used for mosquito control program.
In this study, search for new mosquitocidal bacterium was attempted from the gut content of the fresh water fish Clarias batrachus (walking cat fish) which resulted in the isolation of a highly potential mosquitocidal bacterium. The isolate was identified as Bacillus cereus VCRC 641 by Bacillus species specific molecular markers ilvD, pur and pycA gene sequence analysis. Laboratory mosquito larval toxicity assay (bioassay) against mosquito larvae revealed that this new isolate was highly potent against Culex quinquefasciatus followed by Aedes aegypti and Anopheles stephensi. The lethal concentration values at LC50 for these three mosquito species were 0.001, 0.004 and 0.007mg/ L respectively. Therefore, in the present study, this is the first report that a highly potential mosquitocidal bacteria of B. cereus VCRC 641 was isolated from the gut content of Clarias batrachus and suggested that it can be used for mosquito vector control program.
Mosquito vector transmit serious infectious diseases that include dengue, chikungunya, malaria, filariasis, leishmaniasis, Japanese encephalitis, west Nile fever, yellow fever and rift valley fever. Insecticides-based control measures have historically and currently been an important control approach against major mosquito-borne diseases. Chemical pesticides, on the other hand, are non-selective and can harm other beneficial organisms. Controlling mosquitoes with entomopathogenic bacteria is a convincing, ecologically acceptable alternative to chemical pesticides. Bacillus thuringiensis israelensis and Bacillus sphaericus are insecticidal microorganisms which are spore forming and these bacteria are the most extensively utilised alternative mosquito control agents, considering the rapid development of resistance, especially to B. sphaericus by the larvae of Culex spp. Under this circumstances, it is necessary to find an alternative biological control agents from natural resources. The present review focus mainly on the various strategies to control mosquito vectors.
Bacillus cereus VCRC 641 was found to be an alternate larvicidal bacterial agent which was newly isolated from fresh water fish, Clarias batrachus (walking cat fish). The protein responsible for mosquito toxic effect was separated and purified by Sephacryl S-200 column chromatography and NATIVE PAGE. It was observed that a unique protein with molecular weight of 70kDa was the responsible factor for mosquito killing effect. Further analysis of the protein by liquid chromatography-mass spectrometry (LC-MS) it was identified as “Uncharacterized Protein”. The length of the uncharacterized protein was around 158bp. The uncharacterized protein was expected to have a molecular mass of 70 kDa, 51 amino acids, confidence score of 78.45 and mass of 206772.57. Therefore, in the present study we report for the first time that uncharacterized protein (70kDa) was the responsible factor for the mosquito killing effect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.